UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key patent expiry, as US hedge fund Citadel took the largest short position ...

In Robert F. Kennedy Jr.’s first interview as secretary of the Department of Health and Human Services, he made multiple ...

HHS Secretary Robert F. Kennedy Jr. plans to axe members of the department’s vaccine-centric panels of outside advisers who he deems to be too cozy with the drug industry.

The pharmaceutical industry is framing itself as a key partner for President Trump and HHS Secretary Robert F. Kennedy Jr. in ...

The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...

The health secretary is planning to remove members of a panel that recommends vaccines if he sees conflicts of interest.

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

A lawyer for the plaintiff in the case said Merck agreed to halting the trial because his team feared that extensive ...

Recently appointed HHS Secretary Robert F. Kennedy Jr. in 2018 helped bring several cases against vaccine maker Merck, ...

The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

Robert F. Kennedy Jr., laying out his early health agenda, said he would examine childhood vaccines, psychiatric drugs and other “formerly taboo” topics in investigating the causes of chronic disease.